Chronic treatment with P5 and Ex4 significantly reduced ectopic lipid deposition in the liver as indicated by a decrease in the number of lipid droplets (Fig
Critical adjustment period Early months require guidance for dosing, tolerance, & progress for long-term success Most GLP-1 programs stop at the prescription Ours starts there starts there your complete care Your personalized GLP-1 care starts with membership personalized GLP-1 care starts with membership Patient voices I speak with the Healthspan team monthly about my protocols and their effects on my bloodwork (which I do quarterly)
These cells have the ability to develop into various types of tissues, including cartilage, bone, or muscle, making them especially effective for treating musculoskeletal conditions
by Bianca Garilli, ND Non-alcoholic fatty liver disease (NAFLD), characterized by fat accumulation in the liver not caused by alcohol consumption, affects up to 25% of people in the US
Physiology matters
The conversation around these medications has evolved rapidly, from being prescribed solely for type 2 diabetes, to expanded use for the treatment of obesity, cardiovascular, kidney, and liver disease, as well as arthritis, sleep apnea and even for the treatment of substance abuse disorder
